Skip to main content
Dan Reuland, MD, MPH - Division of General Medicine and Clinical Epidemiology

Dan Reuland, MD, MPH

Robert A. Ingram Distinguished Professor of Medicine

Program Director, Carolina Cancer Screening Initiative (CCSI), Lineberger Comprehensive Cancer Center

Resources

Dan Reuland, MD, MPH

Robert A. Ingram Distinguished Professor of Medicine

Program Director, Carolina Cancer Screening Initiative (CCSI), Lineberger Comprehensive Cancer Center

Areas of Interest

Cancer screening implementation, shared medical decision making, health-related communication and behavior in primary care practice and health systems

About

Dr. Reuland’s primary research focus is in applied translational research studying how to improve the delivery of guideline-recommended cancer screening in health care and public health practice. In recent years he has led a study funded by the National Cancer Institute’s Cancer Moonshot program testing a colorectal cancer screening intervention in North Carolina Federally Qualified Health Centers. He also participates in multi-disciplinary efforts to study, develop, and evaluate policies and processes for implementing lung cancer screening in health systems. Dr. Reuland is the Director of the Carolina Cancer Screening Initiative (CCSI) within the UNC Lineberger Comprehensive Cancer Center. Supported by the University Cancer Research Fund as well as external research grants, CCSI infrastructure facilitates applied research in partnership with academic, government, and community health partners that can lead to improved cancer screening in North Carolina. His recent work has focused on emerging cancer screening technologies. Along with UNC Lineberger colleagues he is part of a national effort to establish the NCI’s new Cancer Screening Research Network (CSRN). The CSRN is now conducting clinical trials to evaluate new screening approaches and technologies such as multicancer detection assays. These blood‑based tests have the potential to identify cancers at earlier stages, but their performance, clinical pathways, and population‑level impact are not yet well understood.

Dr. Reuland previously served as a faculty member in the Community Engagement Core in the North Carolina Translational and Clinical Sciences (NC TraCS) Institute, where his work has included promoting the inclusion of Spanish-speaking Latin populations in translational health research. He also holds an adjunct faculty appointment in the UNC Gillings School of Global Public Health, Department of Health Policy and Management, as well as center appointments/ memberships in the Lineberger Comprehensive Cancer Care Center – Cancer Prevention and Control Program, and Cecil G. Sheps Center for Health Services Research.

  • BA

    University of Michigan

  • MD

    Johns Hopkins University

  • Residency

    Yale University School of Medicine

  • Fellowship

    University of North Carolina at Chapel Hill

  • MPH

    University of North Carolina Gillings School of Global Public Health